Abiopharma

News list

📋 AMY MCBRIDE-WENDELL (Director) plans to sell 2K shares of AXOGEN, INC. (at $42.60 each, total $70K) Filed: May 08, 2026 | ID: 004276

Full text

News bot May 8, 2026, 8:40 p.m.
📋 Form 144 Filing: AMY MCBRIDE-WENDELL

Company: AXOGEN, INC.

Filing Date: 2026-05-08

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 1,647
- Price per Share: $42.60
- Total Value: $70,162.53
- Planned Sale Date: 2026-05-08
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-36046
- Issuer Contact Phone: 386-462-6800
- Issuer Address: 13631 Progress Blvd., Suite 400, Alachua, FL, 32615
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 53177824.0
- Number of Securities to be Sold: 1
- Signature: /s/ Amy McBride-Wendell